Items where authors include "Peckham, N."

Article

Abhishek, A. orcid.org/0000-0003-0121-4919, Peckham, N. orcid.org/0000-0003-1066-0726, Pade, C. orcid.org/0000-0003-0626-2346 et al. (22 more authors) (2025) Temporary 2-week suspension of methotrexate treatment to enhance COVID-19 vaccine response in people with immune-mediated inflammatory diseases: the VROOM RCT. Efficacy and Mechanism Evaluation. ISSN 2050-4365

Abhishek, A., Peckham, N., Pade, C. et al. (65 more authors) (2024) Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial. The Lancet Rheumatology, 6 (2). e92-e104. ISSN 2665-9913

Abhishek, A., Boyton, R.J., McKnight, Á. et al. (15 more authors) (2022) Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study). BMJ Open, 12 (5). e062599. ISSN 2044-6055

Mellor, K., Eddy, S., Peckham, N. et al. (7 more authors) (2021) Progression from external pilot to definitive randomised controlled trial : a methodological review of progression criteria reporting. BMJ Open, 11 (6). e048178.

Rombach, I. orcid.org/0000-0003-3464-3867, Knight, R., Peckham, N. et al. (2 more authors) (2020) Current practice in analysing and reporting binary outcome data—a review of randomised controlled trial reports. BMC Medicine, 18. 147. ISSN 1741-7015